Cargando…
Immunosuppressive effects of hydroxychloroquine and artemisinin combination therapy via the nuclear factor-κB signaling pathway in lupus nephritis mice
Lupus nephritis (LN) is one of the most common and severe manifestations of systemic lupus erythematosus, leading to permanent renal damage and chronic kidney disease. Hydroxychloroquine (HCQ) serves a protective role against lupus-associated clinical manifestations and medical complications; howeve...
Autores principales: | Liang, Ning, Zhong, Yanchun, Zhou, Jie, Liu, Bihao, Lu, Ruirui, Guan, Yezhi, Wang, Qi, Liang, Chunlin, He, Yu, Zhou, Yuan, Song, Jianping, Zhou, Jiuyao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795753/ https://www.ncbi.nlm.nih.gov/pubmed/29456648 http://dx.doi.org/10.3892/etm.2018.5708 |
Ejemplares similares
-
Polymorphisms of the artemisinin resistant marker (K13) in Plasmodium falciparum parasite populations of Grande Comore Island 10 years after artemisinin combination therapy
por: Huang, Bo, et al.
Publicado: (2015) -
Zebra bodies in lupus nephritis after hydroxychloroquine therapy
por: Singh, Anshima, et al.
Publicado: (2023) -
Hydroxychloroquine administration exacerbates acute kidney injury complicated by lupus nephritis
por: An, Ning, et al.
Publicado: (2022) -
Strongyloides Duodenitis in an Immunosuppressed Patient with Lupus Nephritis
por: Jegadeesan, Ramprasad, et al.
Publicado: (2018) -
Zhen-Wu-Tang Protects IgA Nephropathy in Rats by Regulating Exosomes to Inhibit NF-κB/NLRP3 Pathway
por: Li, Honglian, et al.
Publicado: (2020)